Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |